Substrate-Dependent Sensitivity of SIRT1 to Nicotinamide Inhibition

被引:8
|
作者
Rymarchyk, Stacia [1 ]
Kang, Wenjia [2 ]
Cen, Yana [2 ,3 ]
机构
[1] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Colchester, VT 05446 USA
[2] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23219 USA
[3] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23219 USA
关键词
SIRT1; epigenetics; deacetylation; NAM inhibition; base exchange; solvent isotope effect;
D O I
10.3390/biom11020312
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SIRT1 is the most extensively studied human sirtuin with a broad spectrum of endogenous targets. It has been implicated in the regulation of a myriad of cellular events, such as gene transcription, mitochondria biogenesis, insulin secretion as well as glucose and lipid metabolism. From a mechanistic perspective, nicotinamide (NAM), a byproduct of a sirtuin-catalyzed reaction, reverses a reaction intermediate to regenerate NAD(+) through "base exchange", leading to the inhibition of the forward deacetylation. NAM has been suggested as a universal sirtuin negative regulator. Sirtuins have evolved different strategies in response to NAM regulation. Here, we report the detailed kinetic analysis of SIRT1-catalyzed reactions using endogenous substrate-based synthetic peptides. A novel substrate-dependent sensitivity of SIRT1 to NAM inhibition was observed. Additionally, SIRT1 demonstrated pH-dependent deacetylation with normal solvent isotope effects (SIEs), consistent with proton transfer in the rate-limiting step. Base exchange, in contrast, was insensitive to pH changes with no apparent SIEs, indicative of lack of proton transfer in the rate-limiting step. Consequently, NAM inhibition was attenuated at a high pH in proteated buffers. Our study provides new evidence for "activation by de-repression" as an effective sirtuin activation strategy.
引用
收藏
页码:1 / 16
页数:14
相关论文
共 50 条
  • [21] SUBSTRATE-DEPENDENT INHIBITION OF PROTEIN KINASE-C BY SPECIFIC INHIBITORS
    JUNCO, M
    DIAZGUERRA, MJM
    BOSCA, L
    FEBS LETTERS, 1990, 263 (01) : 169 - 171
  • [22] Substrate-dependent isothiocyanate toxicity
    Yakabe, L. E.
    MacDonald, J. D.
    Kliebenstein, D. J.
    PHYTOPATHOLOGY, 2004, 94 (06) : S112 - S113
  • [23] Nicotinamide-mediated inhibition of SIRT1 deacetylase is associated with the viability of cancer cells exposed to antitumor agents and apoptosis
    Wang, Tong
    Cui, Huixia
    Ma, Nan
    Jiang, Youhong
    ONCOLOGY LETTERS, 2013, 6 (02) : 600 - 604
  • [24] INHIBITION OF SIRT1 IMPAIRS THE GROWTH OF HCC TUMOURS
    Portmann, S.
    Fahrner, R.
    Lechleiter, A.
    Overney, S.
    Tschan, M.
    Candinas, D.
    Stroka, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S123 - S124
  • [25] Inhibition of SIRT1 impairs growth and autophagy in HCC
    Portmann, Simone
    Schwarz, Christa
    Tschan, Mario
    Candinas, Daniel
    Stroka, Deborah
    SWISS MEDICAL WEEKLY, 2012, 142 : 6S - 6S
  • [26] Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1
    Bitterman, KJ
    Anderson, RM
    Cohen, HY
    Latorre-Esteves, M
    Sinclair, DA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (47) : 45099 - 45107
  • [27] The effects of SIRT1 inhibitors nicotinamide and Ex-527 on lymphoma cells
    Guardi, Manuela
    Pistoni, Mariaelena
    Frazzi, Raffaele
    CANCER RESEARCH, 2017, 77
  • [28] Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes
    Maiese, Kenneth
    CURRENT NEUROVASCULAR RESEARCH, 2021, 17 (05) : 765 - 783
  • [29] Nicotinamide protects against diabetic kidney disease through regulation of Sirt1
    Yang, Yeping
    Huang, Jinya
    Xie, Lijie
    Wang, Yilin
    Guo, Shizhe
    Wang, Meng
    Shao, Xiaoqing
    Liu, Wenjuan
    Wang, Yi
    Li, Qin
    Wu, Xia
    Zhang, Zhaoyun
    Zeng, Fangfang
    Gong, Wei
    ENDOCRINE, 2024, 85 (01) : 99 - 121
  • [30] Nicotinamide induces liver regeneration and improves liver function by activating SIRT1
    Wan, Hai-Feng
    Li, Jia-Xin
    Liao, Hao-Tian
    Liao, Ming-Heng
    Luo, Lin
    Xu, Lin
    Yuan, Ke-Fei
    Zeng, Yong
    MOLECULAR MEDICINE REPORTS, 2019, 19 (01) : 555 - 562